Category: Penny Stock NewsSort
Orexigen (OREX) Contrave Light Study Results, Hanwha SolarOne (HSOL) Gets Supply Deal to Canada
CombiMatrix (CBMX) Skyrockets on Contract, Oncolytics Biotech (ONCY) Positive Data on REOLYSIN
Intellipharmaceutics (IPCI), POZEN (POZN), Nektar (NKTR), Biotech Radar Attractors
VisionChina (VISN) Expectancies on Results, Biostar Pharma (BSPM) Soared on Numbers, Tetra Tech (TTEK) Upgraded
Cadence Pharmaceuticals Surges On OFIRMEV Update (NASDAQ:CADX)
As the bio pharmaceuticals market is expected to reach $199.7 billion by the end of 2013, we would like for you to observe Cadence Pharmaceuticals stock symbol CADX. Cadence Pharmaceuticals specializes in acquiring, in-licensing, developing and commercializing proprietary products in the bio pharmaceutical market. The Company is currently a surge of +34.86% Up 2.05 with over 7.8 million shares in play at a price per share value of $7.93 November Friday 15, 2013 3:08PM EST. So whatâs hot about the stock you ask?